Amedeo Smart

Free Medical Literature Service


 

Amedeo

Obstructive Lung Diseases

  Free Subscription

Articles published in
J Investig Allergol Clin Immunol
    June 2022
  1. OTANI T, Iwamoto H, Horimasu Y, Yamaguchi K, et al
    Effect of dupilumab in a patient with severe asthma complicated with recurrent anaphylaxis: a case report.
    J Investig Allergol Clin Immunol. 2022 Jun 27:0. doi: 10.18176/jiaci.0840.
    >> Share

  2. ALMONACID SANCHEZ C, Blanco-Aparicio M, Dominguez-Ortega J, Giner Donaire J, et al
    Validation of the algorithm for the monitoring and control of asthma through telemedicine. The Consensus COMETA Project.
    J Investig Allergol Clin Immunol. 2022 Jun 27:0. doi: 10.18176/jiaci.0841.
    >> Share

  3. PEREZ DE LLANO LA, Cosio BG, Lobato Astiarraga I, Soto Campos G, et al
    First line versus second line use of reslizumab in severe uncontrolled asthma.
    J Investig Allergol Clin Immunol. 2022 Jun 27:0. doi: 10.18176/jiaci.0839.
    >> Share

  4. POSE K, Laorden D, Hernandez N, Villamanan E, et al
    Concomitant Efficacy of Dupilumab for severe atopic dermatitis and comorbid asthma in real-life conditions.
    J Investig Allergol Clin Immunol. 2022 Jun 20:0. doi: 10.18176/jiaci.0837.
    >> Share

  5. OLAGUIBEL JM, Sastre J, Rodriguez JM, Del Pozo V, et al
    Eosinophilia Induced by Blocking the IL-4/IL-13 Pathway: Potential Mechanisms and Clinical Outcomes.
    J Investig Allergol Clin Immunol. 2022;32:165-180.
    >> Share

  6. QUIRCE S, Trigueros JA, Ausin P, Munoz Cano R, et al
    Role of the different healthcare professionals in the management of asthma patients. The GEMA-FORUM IV task force.
    J Investig Allergol Clin Immunol. 2022 Jun 8:0. doi: 10.18176/jiaci.0833.
    >> Share

    May 2022
  7. GONZALEZ O, Picado C, Alobid I, Ramirez J, et al
    Eosinophilic sialodochitis: a rare comorbidity of severe asthma.
    J Investig Allergol Clin Immunol. 2022 May 2:0. doi: 10.18176/jiaci.0817.
    >> Share

  8. DOMINGUEZ-ORTEGA J, Luna-Porta JA, Olaguibel JM, Barranco E, et al
    Exacerbations among patients with asthma are largely dependent on the presence of multimorbidity.
    J Investig Allergol Clin Immunol. 2022 May 2:0. doi: 10.18176/jiaci.0816.
    >> Share

    April 2022
  9. IZQUIERDO E, Rodriguez-Coira J, Delgado-Dolset MI, Gomez-Casado C, et al
    Epithelial Barrier: Protector and Trigger of Allergic Disorders.
    J Investig Allergol Clin Immunol. 2022;32:81-96.
    >> Share

  10. URIARTE SA, Gronlund H, Wintersand A, Bronge J, et al
    Clinical and Immunologic Changes due to Subcutaneous Immunotherapy With Cat and Dog Extracts Using an Ultrarush Up-Dosing Phase: A Real-Life Study.
    J Investig Allergol Clin Immunol. 2022;32:133-140.
    >> Share

  11. BARROSO B, Valverde-Monge M, Alobid I, Olaguibel JM, et al
    Smell improvement by anti-IgE and anti-IL 5 biologics in patients with CRSwNP and severe asthma. A real life study.
    J Investig Allergol Clin Immunol. 2022 Apr 12:0. doi: 10.18176/jiaci.0812.
    >> Share

    March 2022
  12. SALOMONSSON M, Cardenas EI, Dahlin JS, Kalm-Stephens P, et al
    The proportion of FceRI+ blood monocytes increases with the degree of IgE sensitization in asthma.
    J Investig Allergol Clin Immunol. 2022 Mar 2:0. doi: 10.18176/jiaci.0797.
    >> Share

    February 2022
  13. MIRALLES LOPEZ JC, Andujar-Espinosa R, Bravo-Gutierrez FJ, Castilla-Martinez M, et al
    Effectiveness of benralizumab in severe eosinophilic asthma under routine clinical practice.
    J Investig Allergol Clin Immunol. 2022 Feb 11:0. doi: 10.18176/jiaci.0793.
    >> Share

    January 2022
  14. DELGADO ROMERO J, Blanco-Aparicio M, Cisneros Serrano C, Diaz-Perez D, et al
    Biological therapy at-home administration support for patients with severe asthma BioCart(c).
    J Investig Allergol Clin Immunol. 2022 Jan 24:0. doi: 10.18176/jiaci.0786.
    >> Share

  15. VALVERDE-MOLINA J, Fernandez-Nieto M, Torres-Borrego J, Lozano Blasco J, et al
    Transition of adolescents with severe asthma from pediatric to adult care in Spain: the STAR consensus.
    J Investig Allergol Clin Immunol. 2022 Jan 12:0. doi: 10.18176/jiaci.0780.
    >> Share

    December 2021
  16. LEIRIA-PINTO P, Carreiro-Martins P, Peralta I, Marques J, et al
    Factors Associated With Asthma Control in 121 Preschool Children.
    J Investig Allergol Clin Immunol. 2021;31:471-480.
    >> Share

  17. DELGADO-ROMERO J, Pereyra-Rodriguez JJ
    Asthma mortality in Spain from 1980 to 2019. Trends and perspectives in new treatment era.
    J Investig Allergol Clin Immunol. 2021 Dec 13:0. doi: 10.18176/jiaci.0771.
    >> Share

    November 2021
  18. ANTONICELLI L, Tontini C, Garritani MS, Piga MA, et al
    Efficacy of mepolizumab in patients with concomitant severe eosinophilic asthma and severe chronic urticaria: an example of personalized medicine?
    J Investig Allergol Clin Immunol. 2021 Nov 29:0. doi: 10.18176/jiaci.0770.
    >> Share

  19. VALERO A, Molina J, Nuevo J, Simon S, et al
    Economic consequences of the overuse of short-acting beta-adrenergic agonists (SABA) in the treatment of asthma in Spain.
    J Investig Allergol Clin Immunol. 2021 Nov 26:0. doi: 10.18176/jiaci.0767.
    >> Share

  20. KALM-STEPHENS P, Nordvall L, Janson C, Malinovschi A, et al
    Sex differences in baseline risk factors for the incidence of asthma between early adolescence and young adulthood.
    J Investig Allergol Clin Immunol. 2021 Nov 18:0. doi: 10.18176/jiaci.0763.
    >> Share

  21. IZQUIERDO JL, Almonacid C, Campos C, Morena D, et al
    Systemic Corticosteroids in Patients with Bronchial Asthma: A Real-Life Study.
    J Investig Allergol Clin Immunol. 2021 Nov 11:0. doi: 10.18176/jiaci.0765.
    >> Share

    October 2021
  22. PACHOLCZAK-MADEJ R, Kuszmiersz P, Iwaniec T, Zareba L, et al
    Endothelial Dysfunction and Pentraxin-3 in Clinically Stable Adult Asthma Patients.
    J Investig Allergol Clin Immunol. 2021;31:417-425.
    >> Share

  23. VILLALOBOS-VIOLAN V, Betancor D, Mahillo-Fernandez I, Sastre J, et al
    Nonasthmatic Eosinophilic Bronchitis and Asthma Development: analysis of biomarkers.
    J Investig Allergol Clin Immunol. 2021 Oct 15:0. doi: 10.18176/jiaci.0738.
    >> Share

  24. LEAL M, Paciencia I, Farraia M, Cavaleiro Rufo J, et al
    Airborne Food Allergen and Aeroallergen Levels in Health Care Settings: An Unaccounted for but Potentially Relevant Source of Exposure?
    J Investig Allergol Clin Immunol. 2021;31:426-432.
    >> Share

    September 2021
  25. DAVILA I, Campo P, Cimbollek S, Almonacid Sanchez C, et al
    Cluster sub-analysis of patients with severe asthma who responded to omalizumab.
    J Investig Allergol Clin Immunol. 2021 Sep 28:0. doi: 10.18176/jiaci.0731.
    >> Share

  26. GIL-MARTINEZ M, Rodrigo-Munoz JM, Sastre B, Canas JA, et al
    Serum microRNAs catalog asthmatic patients by phenotype.
    J Investig Allergol Clin Immunol. 2021 Sep 6:0. doi: 10.18176/jiaci.0753.
    >> Share

  27. DELGADO ROMERO J, Nunez Palomo S, Urendez Ruiz AM, Gomez Ruiz F, et al
    Referral criteria for asthma and the pandemic: new challenges, new responses.
    J Investig Allergol Clin Immunol. 2021 Sep 3:0. doi: 10.18176/jiaci.0747.
    >> Share

    July 2021
  28. ALMONACID SANCHEZ C, Melero Moreno C, Quirce Gancedo S, Sanchez-Herrero MG, et al
    PAGE Study: Summary of a Study Protocol to Estimate the Prevalence of Severe Asthma in Spain Using Big Data Methods.
    J Investig Allergol Clin Immunol. 2021;31:308-315.
    >> Share

    June 2021
  29. EXTREMERA ORTEGA AM, Moreno Lozano L, Gonzalez Jimenez OM, Borja Segade J, et al
    Findings in Chest High-Resolution Computed Tomography in Severe Asthma.
    J Investig Allergol Clin Immunol. 2021 Jun 29:0. doi: 10.18176/jiaci.0725.
    >> Share

  30. PEREZ DE LLANO L, Blanco Cid N, Ortiz Piquer M, Dacal Rivas D, et al
    Compassionate Use of a Single Dose of Benralizumab in a Near-Fatal Asthma Exacerbation.
    J Investig Allergol Clin Immunol. 2021;31:268-270.
    >> Share

  31. JACOME C, Pereira R, Almeida R, Amaral R, et al
    Validation of App and Phone Versions of the Control of Allergic Rhinitis and Asthma Test (CARAT).
    J Investig Allergol Clin Immunol. 2021;31:270-273.
    >> Share

  32. BENZECRY V, Pravettoni V, Segatto G, Marzano AV, et al
    Type 2 Inflammation: Atopic Dermatitis, Asthma, and Hypereosinophilia Successfully Treated With Dupilumab.
    J Investig Allergol Clin Immunol. 2021;31:261-263.
    >> Share

    April 2021
  33. BARRANCO P, Palao P, Ruiz I, Dominguez-Ortega J, et al
    Relationship Between IgE-Mediated Sensitization to Staphylococcus aureus Enterotoxin B, Asthma Severity, and Atopy.
    J Investig Allergol Clin Immunol. 2021;31:170-173.
    >> Share

  34. DELGADO ROMERO J, Miralles Lopez JC, Alvarez Puebla M, Fernandez Ibanez E, et al
    Severe Asthma Units Accredited by the Spanish Society of Allergology and Clinical Immunology (SEAIC): Experience and Future.
    J Investig Allergol Clin Immunol. 2021;31:182-184.
    >> Share

  35. DELGADO J, Martinez-Moragon E, Fernandez-Sanchez T
    Factors Affecting the Success of Step-up Therapy in Patients With Moderate-Severe Asthma: A Real-Life Study.
    J Investig Allergol Clin Immunol. 2021;31:145-150.
    >> Share

  36. TEJEDOR-ALONSO MA, Farias-Aquino E, Perez-Fernandez E, Moro-Moro M, et al
    Association Between Severity of Anaphylaxis and Co-occurrence of Respiratory Diseases: A Systematic Review and Meta-analysis of Observational Studies.
    J Investig Allergol Clin Immunol. 2021;31:132-144.
    >> Share

  37. DIAZ-CAMPOS RM, Garcia-Moguel I, Pina-Maiquez I, Fernandez-Rodriguez C, et al
    Prevalence and influence of COVID19 in asthma control and lung function in severe asthma patients under biological treatment.
    J Investig Allergol Clin Immunol. 2021 Apr 15:0. doi: 10.18176/jiaci.0695.
    >> Share

  38. BUENDIA JA, Acuna-Cordero R, Rodriguez-Martinez CE
    Budget impact analysis of Fractional Exhaled Nitric Oxide Monitoring for the Management of Childhood Asthma: The Colombian National Health System perspective.
    J Investig Allergol Clin Immunol. 2021 Apr 13:0. doi: 10.18176/jiaci.0690.
    >> Share

    March 2021
  39. PLAZA V, Trigueros JA, Cisneros C, Dominguez-Ortega J, et al
    The Importance of Small Airway Dysfunction in Asthma. The GEMA-FORUM III Task Force.
    J Investig Allergol Clin Immunol. 2021 Mar 12:0. doi: 10.18176/jiaci.0686.
    >> Share

    February 2021
  40. DELGADO J, Davila IJ, Dominguez-Ortega J
    Clinical Recommendations for the Management of Biological Treatments in Severe Asthma Patients: A Consensus Statement.
    J Investig Allergol Clin Immunol. 2021;31:36-43.
    >> Share

  41. MIRALLES LOPEZ JC, Escudero Pastor AI, Carbonell Martinez A, Navarro Garrido C, et al
    Benralizumab in Real Life.
    J Investig Allergol Clin Immunol. 2021;31:87-88.
    >> Share

  42. PLAZA V, Giner J, Curto E, Alonso-Ortiz MB, et al
    Assessing Adherence by Combining the Test of Adherence to Inhalers With Pharmacy Refill Records.
    J Investig Allergol Clin Immunol. 2021;31:58-64.
    >> Share

    January 2021
  43. SATO H, Miyata Y, Inoue H, Tanaka A, et al
    Efficacy of Mepolizumab Extended Interval Dosing For Two Asthmatic Cases with Chronic Eosinophilic Pneumonia.
    J Investig Allergol Clin Immunol. 2021 Jan 26:0. doi: 10.18176/jiaci.0671.
    >> Share

  44. BETANCOURT A, Zapatero A, Pola-Bibian B, Dominguez-Ortega J, et al
    Impact of Short-Term Exposure to Below Recommended PM10 Pollution Levels on Asthma Exacerbations.
    J Investig Allergol Clin Immunol. 2021 Jan 12:0. doi: 10.18176/jiaci.0663.
    >> Share

    November 2020
  45. SERRANO P, Navas A, Ruiz-Leon B, Herrero L, et al
    Seasonal administration of omalizumab in patients with uncontrolled asthma and sensitization to olive pollen.
    J Investig Allergol Clin Immunol. 2020 Nov 25:0. doi: 10.18176/jiaci.0657.
    >> Share

  46. KUROSAWA M, Shimizu Y, Sutoh Y, Sutoh E, et al
    Un-Sustained Response to Benralizumab in Eosinophilic Asthma with Previous 3 Year Mepolizumab Administration.
    J Investig Allergol Clin Immunol. 2020 Nov 2:0. doi: 10.18176/jiaci.0652.
    >> Share

    October 2020
  47. CABALLERO ML, Dominguez J, Nin-Valencia AR, Sanchez-Ocando H, et al
    Eosinophil Count in Induced Sputum Could Be More Sensitive Than In Peripheral Blood to Phenotype Patients with Severe Eosinophilic Asthma.
    J Investig Allergol Clin Immunol. 2020 Oct 8:0. doi: 10.18176/jiaci.0647.
    >> Share

    April 2020
  48. SHIMIZU Y, Kurosawa M, Sutoh Y, Sutoh E, et al
    Long-Term Treatment With Anti-Interleukin 5 Antibodies in a Patient with Chronic Eosinophilic Pneumonia.
    J Investig Allergol Clin Immunol. 2020;30:154-155.
    >> Share

  49. OLAGUIBEL A, Oleaga M, Iraola A, Cortaberria R, et al
    Exhaled Nitric Oxide (eNO) Measurements With the New evernoa Device Are Valid and Reproducible Through an Extended Range of eNO Levels.
    J Investig Allergol Clin Immunol. 2020;30:147-149.
    >> Share

    January 2020
  50. URIARTE SA, Sastre J
    Subcutaneous Immunotherapy With High-Dose Cat and Dog Extracts: A Real-life Study.
    J Investig Allergol Clin Immunol. 2020;30:169-174.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016